Vitamin D for Cardiovascular Disease

Verdict: Does not prevent cardiovascular disease

For preventing cardiovascular disease, vitamin D supplements do not work: large, high-quality randomized trials and meta-analyses consistently show no reduction in heart attacks, strokes, or cardiovascular death. Vitamin D remains important for bone and general health, but it is not a tool for protecting the heart.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

This earns a Counter-Evidence grade because the negative evidence is unusually mature and consistent, not merely thin. The landmark VITAL trial randomized 25,871 adults to 2,000 IU/day and found no reduction in major cardiovascular events (HR 0.97, 95% CI 0.85-1.12; PMID 31733345). Two large meta-analyses agree: one pooling over 83,000 people across 21 trials showed no effect on major events (RR 1.00, 95% CI 0.95-1.06; PMID 31215980), and another of more than 70,000 people found no benefit for cardiovascular death, stroke, or heart attack (PMID 35956336).

Major clinical authorities reinforce this. The Cleveland Clinic, Harvard Health, and the American Heart Association all state that vitamin D supplements do not lower cardiovascular risk, while the Mayo Clinic cautions that the observed link between low vitamin D and heart disease is a correlation, not proof of cause.

Two caveats matter. Regulators like the FDA, EFSA, and NHS endorse vitamin D, but only as an essential nutrient for bone, immune, and calcium roles, not for heart protection. And high doses, or combined calcium-plus-vitamin-D, may carry harm signals such as vascular calcification and higher stroke risk, so more is not better.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.25
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
86%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.20
L5 Clinical bodiesAuthoritative stance
0.21
L3 MechanismPlausibility
0.25
L11 AI re-checkIndependent read
0.30
L1 ExamineGlobal benchmark
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.254
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高階證據未達主導 (0 positive vs 1 negative),由 raw_score 決定
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials
PMID: 31733345 2020 RCT (double-blind) n = 25,871
Finding: No significant reduction in major CVD events (HR 0.97, 95% CI 0.85-1.12); 805 events total (396 vitD vs 409 placebo).
🟢 High quality Government Effect size: [object Object]
View on PubMed
Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis
PMID: 31215980 2019 統合分析 n = 83,291
Finding: No association with reduced MACE (RR 1.00, 95% CI 0.95-1.06; P=0.85). MI, stroke, all-cause mortality also null.
🟢 High quality Mixed funding Effect size: [object Object]
View on PubMed
Association of Vitamin D Supplementation with Cardiovascular Events: A Systematic Review and Meta-Analysis
PMID: 35956336 2022 系統性回顧 n = 70,278
Finding: No association with lower CV risk: CV mortality RR 0.96 (0.88-1.06), stroke RR 1.05 (0.92-1.20), MI RR 0.97 (0.87-1.09), total CV events RR 0.97 (0.91-1.04).
🟢 High quality Government Effect size: [object Object]
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Vitamin D-3 is recognized as GRAS source↗
L4b EU EFSA
Supportive
cause and effect relationship has been established source↗
L4c UK NHS
Supportive
everyone should consider taking a daily vitamin D supplement during the autumn and winter source↗
L4d TW TFDA / 衛福部
Supportive
每日維生素D攝取量需達10微克 source↗
L4e WHO
Cautious
not recommended for all pregnant women source↗
L5a NIH Office of Dietary Supplements
Supportive
Vitamin D is a fat-soluble vitamin source↗
L5b Mayo Clinic
Cautious
association does not mean low vitamin D causes source↗
L5c Cleveland Clinic
Against
vitamins and dietary supplements have virtually no benefits source↗
L5d Harvard Health
Against
taking vitamin D supplements does not appear to lower that risk source↗
L5e Specialty Society (condition-mapped)
Against
vitamin D supplements do not reduce the risk source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cardiovascular-disease-INT-vitamin-d-001 繁體中文版 →